CHALLENGE
Expansion at a rapidly growing biotech company created issues with trying to scale and maintain control of biological sample inventories.
DETAILS
- Rapid addition of personnel and projects led to the lack of a standardized system in place for the client’s scientists to label and track the samples being used.
- Individuals had their own unique nomenclature and organizational methods.As the organization grew, the company experienced personnel turnover and inventory became increasingly disorganized.
- People were spending hours trying to locate and confirm that they’d obtained the right biological samples,costing the organization time and money.
- A substantial amount of rework was required as scientists often were not completely confident in what reagents were available.

SOLUTION
In order to best resolve this issue, an ABS Bio Business Development Manager worked with the client to understand not only the present problem, but the root cause and what success would look like long-term. ABS Bio collaborated with the client to design a solution that fit their immediate & future needs, which included the following:
- Inventory was relabeled using a new standardized system: creating inventory Standard Operating Procedures(SOPs) for addition and removal of materials
- Reagents were physically reorganized and logged
- A formal inventory and historical records necessary for the client were created
- Important documents were linked to their inventory for easy access by all employees
BENEFITS
ABS was able to improve efficiency for lab personnel by following SOPs that provides a consistent and repeatable method to quickly access historical data and a reliable means of locating sample inventories which:
- Increased researchers’ confidence in the available inventory
- Confirmed correct labeling through linked records
- Reduced rework, saving time and money
- Increased control and accuracy of their bioreagent inventory for inventory access and removal

HARMINDER SINGH, M.D.
Business Development Director, ABS Bio
15+ years in life sciences
Biospecimen operations expert
Precision medicine research
Harminder Singh, M.D. is Business Development Director at ABS Bio. He joined ABS Bio from Cureline, where he was instrumental in leading biospecimen operations. He brings more than 15 years of experience in the life sciences industry and is a recognized expert in human biospecimen sourcing, management, and global clinical research. Dr. Singh is actively engaged in designing and executing research projects involving human biospecimens to help develop precision medicine therapies. He has a strong track record of building and maintaining long-term partnerships with clinical networks and pharmaceutical/biotechnology clients.